Home > Diagnoses & Conditions > Tourette Syndrome > Treatment & Management
Tourette Syndrome - Treatment & Management
Primary Care Roles
Most children and youth with Tourette syndrome (TS) can be followed over time within their Medical Home, with surveillance and targeted screening for problems associated with tics and associated conditions. Ongoing education and support provided to the patient and family should emphasize access to resources that provide information about TS, including the Tourette Syndrome Association (TSA). Many people with TS will never require any treatment for TS beyond this.Consultation for evaluation and management support may be indicated at the time of suspicion or confirmation of diagnosis, depending on provider comfort with the diagnosis and on the severity of TS and associated conditions, and if a medication trial is being considered.
When indicated, the Medical Home will coordinate a team approach that may include help from psychology, the school, and possibly consultations with neurology, psychiatry, or developmental pediatrics, depending upon availability and local expertise. The Medical Home also serves to ensure communication among all involved. A Family Care Notebook can help families maintain these networks of communication (see Care notebook info from the AAP Medical Home site, and the Portal Care Notebook on this website).
Providing valid information about TS to the child and family, peers, and educators is a mainstay of management. Effective child advocacy and, for older youth, self-advocacy depend on positive regard and solid self-esteem. The TSA provides excellent resources for these purposes, including the Youth Ambassador Program; educational supports; and information regarding legal protections (TS is now included under IDEA law as "Other Health Impaired"); and more.
Obtaining insurance reimbursement for TS management has historically been difficult, see Tourette syndrome insurance information for details.
Practice Guidelines
Scahill L, Erenberg G, Berlin CM Jr, Budman C, Coffey BJ, Jankovic J, Kiessling L, King RA, Kurlan R, Lang A, Mink J, Murphy
T, Zinner S, Walkup J.
Contemporary assessment and pharmacotherapy of Tourette syndrome.
NeuroRx.
2006;3(2):192-206.
PubMed abstract
Systems
Neurology
General guidelines of pharmacotherapy:
- Because the majority of children diagnosed with TS have co-morbid conditions, it is essential to consider their potential impact. Management should focus on areas of greatest consequence on social, academic, or other areas of function. Most often, the attention deficit hyperactivity disorder (ADHD), learning problems, obsessive compulsive disorder (OCD), anxiety, anger dysregulation, and/or other comorbid conditions warrant first consideration.
- With appropriate information, most children and families will choose not to treat tics.
- Any benefits of medications need to be weighed against potential side effects.
- Most medications used for tic reduction are prescribed "off-label."
- Tics tend to wax and wane over time; before treatment is started, baseline severity should be assessed for several months.
The Yale Global Tic Severity Scale ([Leckman: 1989]) is available to document tics according to type, severity and impairment, but is designed for use by a trained observer.
Other tic-rating scales (for example, see the Tic Severity Checklist
(
16 KB)
) are easier to use in the Medical Home setting.
- The treatment of tics depends on trial and error and frequent clinical visits to assess response and adjust dosage. A provider with expertise in this area is preferable. Because tics naturally wax and wane, medication trials should be conducted over prolonged periods of time (weeks to months). Medications should be started at small doses and increased gradually.
- If medications for tics are to be discontinued, they should be weaned over time, and only under provider guidance.
- When ADHD is co-morbid with TS, the treatment for ADHD should be the same as that for ADHD in a child without tics. Stimulant medications are unlikely to influence tic behavior. As tics will wax and wane naturally, it might appear in some cases that stimulant medication is exacerbating tics. Families should be alerted to the possibility that the course of tics is unpredictable and that tics may intensify naturally, irrespective of ADHD treatment. [Law: 1999] [Nolan: 1999] [Tourette's: 2002] [Erenberg: 2005]
- Although clonidine (see below) may be helpful for the treatment of ADHD symptoms in this population, it is not generally as successful as treatment with stimulants and takes weeks to months to show its effects. Clonidine, however, may decrease the frequency and intensity of tics in some patients, as well as treating attention deficits.
Specific medications
See TS medication table, PDF format (
134 KB)
from [Zinner: 2004] for specific dosing information.
- Neuroleptics - These medications are usually reserved for more severe tics. Although neuroleptics work well, no one medication
is successful in all people with TS at doses that don't cause some side effects. Medications should be started at small doses,
gradually increasing as needed while watching for side effects. The most common side effects are sedation and weight gain,
but neurologic side effects, such as parkinson-like symptoms and tremor, are also possible. Although dystonic reactions are
rare, families should be warned about them in advance.
Some experts prefer the typical neuroleptics. Haloperidol and pimozide are effective, and are the only drugs approved by the FDA for the management of tics in TS. [Silay: 2005] [Sallee: 1997] Others prefer the newer atypicals, of which risperidone and olanzapine have been shown to be effective. [Sandor: 2003] [Budman: 2001] [Bruun: 1996] Families should be told that, after long-term use, neuroleptics need to be discontinued slowly to avoid withdrawal problems, including a rebound in tic frequency, and tardive dyskinesia, a rare but permanent movement disorder particularly involving the mouth. - Alpha-adrenergic agonists - Clonidine and guanfacine (Tenex). Although these may take a few months to decrease tics and are not as likely to be successful as neuroleptics, they are sometimes used because they have no risk of tardive dyskinesia. The most likely side effect of these medications is sedation. They may also be helpful in treating some of the other commonly associated symptoms of TS, especially ADHD. Oral clonidine needs to be taken three to four times a day. The clonidine patch, which needs to be changed only once a week, produces less sleepiness than the oral form but local allergic reactions to the patch are common. Guanfacine has a longer half-life and is reportedly less sedating than clonidine.
- Other - Benzodiazepines, antispasmodic agents (baclofen), dopamine agonists (permax), botulinum injections, and even surgery are sometimes used in refractory cases, where more common medications are not helpful or when their use is limited by side effects. Botulinum toxin (Botox) is most helpful when the patient is experiencing a severe, localized tic, such as in the face or neck. The Botox is injected by an experienced practitioner into the affected muscle groups and lasts for several months.
Subspecialist Collaborations and Other Resources
For the child with severe TS and/or associated problems, co-management with a TS expert may be helpful. The pediatric specialties with the most expertise in TS and associated conditions may vary by community among child neurology, child psychiatry, or developmental pediatrics. If you have chosen a state's resources to be displayed, that region's local experts will be shown below. In addition, children with TS often need assessment by related professionals such as occupational therapy and psychology. Other services, as well as local and national organizations focused on TS, may be found in the Resources section.
Developmental Pediatrics (see Services below for relevant providers)
Often focused on younger children, but may have clinical experience and be helpful in managing children with TS and accessing other resources.
Child Psychiatry (see Services below for relevant providers)
May have considerable clinical experience with TS; particularly helpful when behavioral, learning, or mental health problems are also a concern.
Pediatric Neurology (see Services below for relevant providers)
May have considerable clinical experience with TS; particularly helpful if the child has other neurologic conditions.
Mental Health/Behavior
Subspecialist Collaborations and Other Resources
Child Psychiatry (see Services below for relevant providers)
To help with management of TS and associated disorders.
Child Psychology (see Services below for relevant providers)
To help with evaluation of associated disorders, for IQ and academic achievement testing and for assessment of executive functions, and for counseling for the child and/or family struggling with personal, family, or school functioning. Providers and families should look for a psychologist with experience with TS.
Learning/Education/Schools
58 KB)
for a sample letter for insurance preauthorization.
Subspecialist Collaborations and Other Resources
Child Psychology (see Services below for relevant providers)
In a child with TS complicated by associated disorders and learning problems, a psychological profile may be helpful to guide educational planning.
Neuropsychology (see Services below for relevant providers)
In a child with TS complicated by associated disorders and learning problems, and where brain-based impairment in cognitive function/behavior is suspected (e.g., in a child with TS who also has seizures), a neuro-psychological profile may be helpful to guide educational planning.
Resources
Information & Support
For Professionals
Tourette Syndrome Association, Utah Chapter
Utah chapter of the TSA offering educational advocacy; family support and get togethers; and educational materials.
Tourette Syndrome Association
The only national organization serving children, individuals, and families affected by Tourette Syndrome (TS). Includes six
online CME/CNE programs, programs on Recognition, Diagnosis and Treatment, as well as training for Allied Professionals and
Educators. The website also contains resources for patients and families.
For Parents and Patients
Tourette Syndrome Association, Utah Chapter
Utah chapter of the TSA offering educational advocacy; family support and get togethers; and educational materials.
Tourette Syndrome Association
The only national organization serving children, individuals, and families affected by Tourette Syndrome (TS). Includes six
online CME/CNE programs, programs on Recognition, Diagnosis and Treatment, as well as training for Allied Professionals and
Educators. The website also contains resources for patients and families.
Tourette syndrome (Genetics Home Reference)
Information for patients/families about Tourette syndrome from Genetics Home Reference, sponsored by the National Library
of Medicine
Tourette syndrome internet community
Provides an online interactive community for families and children with TS including email, pen-pals, message boards and chat
rooms.
Practice Guidelines
Scahill L, Erenberg G, Berlin CM Jr, Budman C, Coffey BJ, Jankovic J, Kiessling L, King RA, Kurlan R, Lang A, Mink J, Murphy
T, Zinner S, Walkup J.
Contemporary assessment and pharmacotherapy of Tourette syndrome.
NeuroRx.
2006;3(2):192-206.
PubMed abstract
These guidelines are from the Tourette Syndrome Association Medical Advisory Board: Practice Committee.
Patient Education
TS: Plus
Information about TS and related disorders from Leslie Packer, Ph.D., a psychologist and wife/mother of individuals with TS.
This website offers information aimed at parents and patients about many aspects of TS, with sections on behavior and education.
Tools
TS medication table, PDF format
(
134 KB)
This table, including a list of medications for TS and related information, is adapted from Zinner, 2004.
Tic Severity Checklist
(
16 KB)
An easy to use tic severity scale originally from dbpeds.org. An accurate record of the type and frequency of tics is helpful
to assess the need for and response to medications. This checklist can be downloaded for family use.
Services
For other services related to this condition, browse our Services categories or search our database.
Helpful Articles
PubMed search on Tourette syndrome: review articles over
Tourette's Syndrome Study Group.
Treatment of ADHD in children with tics: a randomized controlled trial.
Neurology.
2002;58(4):527-36.
PubMed abstract
This study offers support for using methylphenidate and/or the combination of methylphenidate/clonidine in the treatment of
ADHD with tic disorder.
Zinner, SH.
Tourette syndrome - much more than tics; Second of two parts, Management tailored to the entire patient.
Contemporary Pediatrics.
2004;21(8):38-49.
/ Full Text
Second of a two part article, including the management of TS as part of management of the patient with possible associated
conditions.
Bagheri, MM, Kerbeshian, J, and Burd, L.
Recognition and management of Tourette's syndrome and tic disorders.
American Family Physician.
1999;59(8):2263-2272, 2274.
Excellent medical information regarding TS for the medical home.
Zinner SH.
Tourette disorder.
Pediatr Rev.
2000;21(11):372-83.
PubMed abstract
An excellent summary with excellent information to guide medication usage.
Dooley JM.
Tic disorders in childhood.
Semin Pediatr Neurol.
2006;13(4):231-42.
PubMed abstract
Goodman WK, Storch EA, Geffken GR, Murphy TK.
Obsessive-compulsive disorder in Tourette syndrome.
J Child Neurol.
2006;21(8):704-14.
PubMed abstract
Kurlan R.
Future and alternative therapies in Tourette syndrome.
Adv Neurol.
2006;99:248-53.
PubMed abstract
McMahon WM, Filloux FM, Ashworth JC, Jensen J.
Movement disorders in children and adolescents.
Neurol Clin.
2002;20(4):1101-24, vii-viii.
PubMed abstract
Gilbert D.
Treatment of children and adolescents with tics and Tourette syndrome.
J Child Neurol.
2006;21(8):690-700.
PubMed abstract
Dornbush, MP and Pruitt, SK.
Teaching the Tiger A Handbook for Individuals Involved in the Education of Students with Attention Deficit Disorders, Tourette
Syndrome or Obsessive-Compulsive Disorder .
Hope Press;
1995.
ISBN-13: 9781878267344
A helpful book regarding the education of children with TS for parents and teachers. Available online.
Authors
| Authors: | Samuel H. Zinner M.D., 5/2008 Lynne M Kerr MD, PhD, 5/2008 |
| Reviewing Author: | Francis Filloux M.D., 7/2008 |
| Content Last Updated: | 8/2008 |
Page Bibliography
Bruun RD, Budman CL.
Risperidone as a treatment for Tourette's syndrome.
J Clin Psychiatry.
1996;57(1):29-31.
PubMed abstract
Budman CL, Gayer A, Lesser M, Shi Q, Bruun RD.
An open-label study of the treatment efficacy of olanzapine for Tourette's disorder.
J Clin Psychiatry.
2001;62(4):290-4.
PubMed abstract
Dornbush, MP and Pruitt, SK.
Teaching the Tiger A Handbook for Individuals Involved in the Education of Students with Attention Deficit Disorders, Tourette
Syndrome or Obsessive-Compulsive Disorder .
Hope Press;
1995.
ISBN-13: 9781878267344
A helpful book regarding the education of children with TS for parents and teachers. Available online.
Erenberg G.
The relationship between tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication: a critical
review.
Semin Pediatr Neurol.
2005;12(4):217-21.
PubMed abstract
Law SF, Schachar RJ.
Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?.
J Am Acad Child Adolesc Psychiatry.
1999;38(8):944-51.
PubMed abstract
Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, Cohen DJ.
The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity.
J Am Acad Child Adolesc Psychiatry.
1989;28(4):566-73.
PubMed abstract
Nolan EE, Gadow KD, Sprafkin J.
Stimulant medication withdrawal during long-term therapy in children with comorbid attention-deficit hyperactivity disorder
and chronic multiple tic disorder.
Pediatrics.
1999;103(4 Pt 1):730-7.
PubMed abstract
Sallee FR, Nesbitt L, Jackson C, Sine L, Sethuraman G.
Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder.
Am J Psychiatry.
1997;154(8):1057-62.
PubMed abstract
Sandor P.
Pharmacological management of tics in patients with TS.
J Psychosom Res.
2003;55(1):41-8.
PubMed abstract
Silay YS, Jankovic J.
Emerging drugs in Tourette syndrome.
Expert Opin Emerg Drugs.
2005;10(2):365-80.
PubMed abstract
Tourette's Syndrome Study Group.
Treatment of ADHD in children with tics: a randomized controlled trial.
Neurology.
2002;58(4):527-36.
PubMed abstract
This study offers support for using methylphenidate and/or the combination of methylphenidate/clonidine in the treatment of
ADHD with tic disorder.
Zinner, SH.
Tourette syndrome - much more than tics; Second of two parts, Management tailored to the entire patient.
Contemporary Pediatrics.
2004;21(8):38-49.
/ Full Text
Second of a two part article, including the management of TS as part of management of the patient with possible associated
conditions.
